Nemec Sarah bought BOLT
December 5, 2025 · Form 4 insider transaction
Nemec Sarah bought 125 shares of Bolt Biotherapeutics, Inc. at $4.61 per share, a transaction worth $575.88. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 61 days after the transaction.
Direction
Acquired (buy-side)
Shares
125
Price
$4.61
Total value
$575.88
InsiderNemec Sarah
RoleOfficer
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateDecember 5, 2025
Filing dateFebruary 4, 2026
Shares owned after1,415
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were acquired under the Issuer's Employee Stock Purchase Plan , in transactions that were exempt under Rule 16b-3(c).